Home » Topics » Conferences

Conferences
RSS

Selective MMP-3 inhibitor PS-508 described at ACS meeting

Aug. 26, 1998

News from ACS: PD-180988 is a potent and selective ETA antagonist

Aug. 26, 1998

Parke-Davis synthesizes potent and selective D4 ligands with antipsychotic potential

Aug. 26, 1998

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Aug. 26, 1998

ACS news flash: R.W. Johnson investigates thrombin inhibitors

Aug. 25, 1998

Lilly describes promising beta3-adrenoceptor agonist at ACS meeting

Aug. 25, 1998

Antiasthma drug candidate enters phase I testing at Pharmacia & Upjohn

Aug. 25, 1998

International team identifies selective P2X antagonists

Aug. 21, 1998

Russian researchers describe immunomodulatory activity of thiethazole

Aug. 20, 1998

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Aug. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...